COSCIENS Biopharma Statistics
Total Valuation
TSX:CSCI has a market cap or net worth of CAD 8.23 million. The enterprise value is 15.16 million.
Important Dates
The next estimated earnings date is Thursday, March 25, 2027.
| Earnings Date | Mar 25, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CSCI has 997,219 shares outstanding. The number of shares has increased by 13.98% in one year.
| Current Share Class | 997,219 |
| Shares Outstanding | 997,219 |
| Shares Change (YoY) | +13.98% |
| Shares Change (QoQ) | -4.69% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | n/a |
| Float | 991,374 |
Valuation Ratios
The trailing PE ratio is 1.23.
| PE Ratio | 1.23 |
| Forward PE | n/a |
| PS Ratio | 0.59 |
| PB Ratio | 0.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 2.17 |
| EV / Sales | 1.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 1.30.
| Current Ratio | 0.66 |
| Quick Ratio | 0.51 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.14 |
Financial Efficiency
Return on equity (ROE) is -93.40% and return on invested capital (ROIC) is -40.21%.
| Return on Equity (ROE) | -93.40% |
| Return on Assets (ROA) | -11.04% |
| Return on Invested Capital (ROIC) | -40.21% |
| Return on Capital Employed (ROCE) | -35.55% |
| Weighted Average Cost of Capital (WACC) | 5.28% |
| Revenue Per Employee | 494,748 |
| Profits Per Employee | 249,960 |
| Employee Count | 28 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.52 |
Taxes
In the past 12 months, TSX:CSCI has paid 11,357 in taxes.
| Income Tax | 11,357 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.09% in the last 52 weeks. The beta is 1.91, so TSX:CSCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -7.09% |
| 50-Day Moving Average | 8.32 |
| 200-Day Moving Average | 8.03 |
| Relative Strength Index (RSI) | 46.17 |
| Average Volume (20 Days) | 472 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CSCI had revenue of CAD 13.85 million and earned 7.00 million in profits. Earnings per share was 6.70.
| Revenue | 13.85M |
| Gross Profit | 6.83M |
| Operating Income | -7.76M |
| Pretax Income | -10.52M |
| Net Income | 7.00M |
| EBITDA | -6.34M |
| EBIT | -7.76M |
| Earnings Per Share (EPS) | 6.70 |
Full Income Statement Balance Sheet
The company has 13.07 million in cash and 20.00 million in debt, with a net cash position of -6.93 million or -6.95 per share.
| Cash & Cash Equivalents | 13.07M |
| Total Debt | 20.00M |
| Net Cash | -6.93M |
| Net Cash Per Share | -6.95 |
| Equity (Book Value) | 15.34M |
| Book Value Per Share | 15.37 |
| Working Capital | -10.94M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -2.15 million and capital expenditures -227,144, giving a free cash flow of -2.37 million.
| Operating Cash Flow | -2.15M |
| Capital Expenditures | -227,144 |
| Depreciation & Amortization | 1.44M |
| Net Borrowing | 14.87M |
| Free Cash Flow | -2.37M |
| FCF Per Share | -2.38 |
Full Cash Flow Statement Margins
Gross margin is 49.32%, with operating and profit margins of -56.05% and 50.52%.
| Gross Margin | 49.32% |
| Operating Margin | -56.05% |
| Pretax Margin | -75.94% |
| Profit Margin | 50.52% |
| EBITDA Margin | -45.74% |
| EBIT Margin | -56.05% |
| FCF Margin | n/a |
Dividends & Yields
TSX:CSCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.98% |
| Shareholder Yield | -13.98% |
| Earnings Yield | 81.16% |
| FCF Yield | -28.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 7, 2026. It was a reverse split with a ratio of 0.333335.
| Last Split Date | Jul 7, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.333335 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |